Noni — Benefits Deep Dive
Noni is the fruit of Morinda citrifolia, a salt-tolerant tree of the coffee family that Polynesian voyagers carried across the Pacific as a dye plant, a famine food and a targeted remedy. Since the mid-1990s it has been sold worldwide as a bottled juice promoted for pain, immunity, energy, blood sugar, blood pressure, cancer and general wellbeing. Those two histories — the ethnobotanical one and the commercial one — are frequently blended together in marketing copy, and the blend is what makes noni hard to read honestly.
This Benefits section documents every major claim made for noni and labels what actually stands behind it. That is the site's standing policy: a claimed use is written down and graded, never quietly dropped, and where a claim sits next to documented harm the harm is stated in the same breath. For noni the honest summary is uncomfortable in both directions. The famous claims rest overwhelmingly on cell-culture and rodent work. At the same time the dismissive position — "harmless fruit juice, ignore it" — is also wrong, because noni carries two real, documented hazards that most supplement pages never mention.
The two hazards, stated up front. First, several independent European hepatology and gastroenterology groups have published case reports of acute hepatitis in people drinking noni juice, including a 29-year-old man whose liver failed after 1.5 L of noni juice over 3 weeks and who needed an urgent liver transplant. The European Food Safety Authority and its predecessor committee reviewed this material, judged the juice acceptable for the general population at ordinary intakes, and left it on the market while explicitly acknowledging the reports and the possibility of individual (idiosyncratic) susceptibility. Second, noni juice is high in potassium — measured at 56.3 mEq/L, similar to orange and tomato juice — and a published report describes hyperkalaemia in a patient with renal insufficiency. For anyone with chronic kidney disease, or on a potassium-sparing diuretic, an angiotensin-converting enzyme inhibitor (ACE inhibitor) or an angiotensin receptor blocker (ARB), that is not a theoretical concern. The man in the published report was following a low-potassium diet and still developed hyperkalaemia (high blood potassium).
One practical point that undercuts almost every dose discussion. Ripe noni smells of ripe cheese and tastes bitter and ammoniacal, so retail "noni juice" is very often blended with grape, blueberry, apple or other sweet juices, sometimes with added sugar. A bottle labelled noni may be a minority noni by volume. That changes the sugar content, changes the potassium content, and means the "30 ml daily" on the label does not correspond to the amount of noni used in any study you might read about. Checking the actual percentage on the ingredient list is the single most useful thing a reader can do.
Table of Contents
- Deep-Dive Articles
- How the Evidence Is Labelled
- The Claim Map at a Glance
- Key Research: Liver Injury and the Case Reports
- Key Research: Potassium, Kidneys and Hyperkalaemia
- Key Research: Pain, Joints and Inflammation
- Key Research: Immune Activity and Antioxidant Chemistry
- Key Research: Energy, Quality of Life and Trial Design
- Traditional Use, Described Accurately
- External Resources
- Connections
- Featured Videos
Deep-Dive Articles
Four articles, each written to be read on its own. The safety article covers the part of the noni story that the promotional literature omits and the part most likely to change what somebody does.
Noni for Pain and Joint Comfort
The oldest and most persistent claim. Rodent analgesia studies going back to 1990, the iridoid and scopoletin mechanisms, what the small arthritis and neck-pain trials did and did not show, and why noni is never a substitute for disease-modifying treatment in inflammatory arthritis.
Read the deep dive →Noni for Immune Function and Antioxidant Defence
Polysaccharide immunomodulation in mice, the antioxidant chemistry of iridoids and scopoletin, the smoker studies that are the strongest human data noni has, and an honest look at the anticancer claim built on damnacanthal in cell culture.
Read the deep dive →Noni for Energy and Quality of Life
"More energy" is the commonest testimonial and the hardest endpoint to trust. What quality-of-life instruments actually measure, why placebo response is enormous for fatigue, the phase I cancer dose-finding study, and how to run a fair personal trial.
Read the deep dive →Noni Safety: Liver Case Reports, Potassium and Interactions
The most important page here. The published hepatitis cases and the animal tests that found no liver injury, what European Food Safety Authority (EFSA) really concluded, the potassium load and who it matters most for, drug interactions, pregnancy, and the warning signs of liver injury.
Read the deep dive →How the Evidence Is Labelled
Every claim in these four articles carries one of five labels. The labels are doing real work here, because noni's literature contains a great deal of laboratory material presented in marketing as though it were clinical proof.
- Randomised clinical trial — tested in humans against a control, with allocation the participants could not choose. Noni has a handful of these. They are small, short, and mostly measure blood markers rather than how anyone feels or what happens to them.
- Preliminary human — open-label studies, dose-finding work, surveys and observational reports. Useful for safety signals and dosing, not for deciding whether something works.
- Preliminary (animal or in vitro) — mice, rats, isolated cells, isolated compounds. This is the bulk of the noni literature. It generates hypotheses; it does not establish benefit in people. An effect of purified damnacanthal on a cancer cell line is not a property of a bottle of juice.
- Traditional use only — documented in Polynesian, Southeast Asian or Australian Aboriginal practice. This is history and is worth respecting as history. It is not evidence of efficacy, and it is often not even evidence about the modern product, because traditional preparations were leaf poultices, root decoctions and fermented fruit taken for specific complaints rather than a sweetened daily juice.
- Not supported — claimed in marketing with no adequate human evidence behind it, or contradicted by what is known. Noni has a lot of these, and the cancer-treatment claim is the one that can cost a life.
The Claim Map at a Glance
Noni is marketed for an essentially unbounded list of conditions, which is itself the clearest signal that the list is not evidence-driven — genuinely effective treatments have narrow indications. Here is the map these articles work through:
- Joint pain, arthritis, neck and back pain — preliminary. Animal analgesia is reasonably consistent; human trials are small. See Pain and Joint Comfort.
- Antioxidant and anti-inflammatory activity — laboratory evidence is solid; the placebo-controlled smoker studies (at least four, published 2009–2013) are the main human biochemical data and they measure surrogate markers over 30 days to one month. See Immune and Antioxidant.
- Immune support — preliminary. Polysaccharide fractions are immunomodulatory in mice. The one human trial that counted infections (2026, 100 adults with repeated colds, fermented noni polysaccharides for 8 weeks) found no significant difference in the number of colds. See Immune and Antioxidant.
- Energy, mood, wellbeing — preliminary human at best, and the endpoints are the ones most vulnerable to expectation effects. See Energy and Quality of Life.
- Cancer treatment — not supported. No human evidence that noni treats or shrinks any cancer. The risk is substitution for effective therapy.
- Diabetes and blood sugar — preliminary (animal). Human trial evidence is inadequate. Not a replacement for glucose-lowering treatment; see Type 2 Diabetes.
- Blood pressure and cholesterol — preliminary human, small and short. See Hypertension for what actually moves these numbers.
- Liver support / "detox" — not supported, and the direction of risk is the opposite. Noni is one of the botanicals with published hepatitis case reports against it. See Liver, Potassium and Safety.
- Kidney or "cleansing" support — not supported, and hazardous in kidney disease because of the potassium load. See Kidney Disease.
Key Research: Liver Injury and the Case Reports
This is the best-documented part of the noni literature, and it is documented in mainstream hepatology journals rather than in advocacy publications. The reports come from several independent European centres and describe a broadly consistent picture: a hepatocellular pattern of injury with markedly raised transaminases, jaundice, fatigue and nausea, appearing weeks to a few months into regular consumption and improving after the juice was stopped.
- Millonig, Stadlmann and Vogel, European Journal of Gastroenterology & Hepatology, 2005 — "Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia)". The index case in the published literature: a 45-year-old man who had drunk noni juice for 3 weeks; a liver biopsy confirmed herbal toxicity, and his liver tests were back in the normal range 1 month after he stopped. PubMed PMID: 15756098
- Stadlbauer and colleagues, World Journal of Gastroenterology, 2005 — "Hepatotoxicity of NONI juice: report of two cases", from Graz, with liver biopsy findings. A 29-year-old man, who had earlier had toxic hepatitis linked to small doses of paracetamol, developed sub-acute liver failure after drinking 1.5 L of noni juice over 3 weeks and needed an urgent liver transplant. A 62-year-old woman with no earlier liver disease developed a self-limited acute hepatitis after 2 L of noni juice over more than 3 months and recovered after stopping. The authors named anthraquinones as the most likely liver-toxic components. PubMed PMID: 16094725
- Yüce, Gülberg, Diebold and Gerbes, Digestion, 2006 — "Hepatitis induced by Noni juice from Morinda citrifolia: a rare cause of hepatotoxicity or the tip of the iceberg?" The title's question has never been definitively answered. A 24-year-old woman, who had also been treated with interferon beta-1a for multiple sclerosis, had drunk noni juice for 4 weeks and was admitted with fulminant hepatitis and suspected beginning acute liver failure; her liver tests were normal within 1 month of stopping the juice. PubMed PMID: 16837801
- Stadlbauer and colleagues, American Journal of Gastroenterology, 2008 — a follow-up case report whose title makes the general point that "herbal" does not mean innocuous, describing a further noni-associated hepatotoxicity case (title: "Herbal does not at all mean innocuous: the sixth case of hepatotoxicity associated with morinda citrifolia (noni)"). PubMed PMID: 18844633
- Kim and colleagues, Journal of Investigative Medicine High Impact Case Reports, 2026 — "A Case Report: Drug-Induced Liver Injury from Prolonged Topical Application of Noni (Morinda citrifolia)". A 60-year-old man developed jaundice, itching all over, dark urine and pale stools, with a cholestatic pattern of liver injury, after using a noni-containing pain-relief cream on his skin for about 8 months (he had stopped it 3 months before the symptoms began). Other causes were ruled out, and his liver tests returned to normal 6 months after he left hospital. The authors write that liver injury from noni used on the skin had not been described before. PubMed PMID: 41805431
- The opposing view — West, Jensen and Westendorf, World Journal of Gastroenterology, 2006, "Noni juice is not hepatotoxic" PubMed PMID: 16773722, and West, Su and Jensen, The Journal of Toxicological Sciences, 2009, "Hepatotoxicity and subchronic toxicity tests of Morinda citrifolia (noni) fruit", reporting hepatotoxicity and subchronic toxicity testing in animals without liver injury at high doses. In that rat study the no-observed-adverse-effect level for freeze-dried noni fruit puree was greater than 6.86 g/kg body weight (equivalent to approximately 90 ml of noni fruit juice per kg), with no tissue changes and no dose-related changes in blood tests, including liver function tests; the authors write that in the human cases "no causal link could be established". PubMed PMID: 19797868
- Background on the class of problem — herb- and supplement-induced liver injury generally, which is a leading cause of otherwise unexplained abnormal liver tests. PubMed topic search.
Evidence tier: case reports (the strongest tier available for rare idiosyncratic injury) in which the liver injury improved after the juice was stopped, set against negative animal toxicology. Anthraquinones are the leading candidate mechanism.
Key Research: Potassium, Kidneys and Hyperkalaemia
Less discussed than the liver signal, easier to predict, and in some ways more immediately dangerous, because severe hyperkalaemia is one of the few electrolyte problems that can kill within hours.
- Mueller, Scott, Sowinski and Prag, American Journal of Kidney Diseases, 2000 — "Noni juice (Morinda citrifolia): hidden potential for hyperkalemia?" measured potassium in noni juice samples at 56.3 mEq/L, similar to orange juice and tomato juice, and described a man with chronic renal insufficiency (long-term kidney disease) who drank noni juice and developed hyperkalaemia despite following a low-potassium diet. PubMed PMID: 10676732
- Dietary potassium in chronic kidney disease — the clinical context for why a "health juice" is a problem in chronic kidney disease. PubMed topic search.
- Drug-induced hyperkalaemia — ACE inhibitors, ARBs, potassium-sparing diuretics, trimethoprim and non-steroidal anti-inflammatory drugs all raise serum potassium, and noni adds to that load. PubMed topic search.
- Herbal products as an unrecognised potassium source — a recurring theme in nephrology case literature. PubMed topic search.
Evidence tier: measured composition plus a published case report. This is the most actionable warning on the whole topic. See Potassium Toxicity for what high potassium does.
Key Research: Pain, Joints and Inflammation
- Younos and colleagues, Planta Medica, 1990 — the classic report of analgesic and behavioural effects of a Morinda citrifolia extract in mice, and the origin of the modern pain claim. Animal. PubMed PMID: 1981810
- Basar and colleagues, Phytotherapy Research, 2010 — analgesic and anti-inflammatory activity of noni fruit preparations in rodent models, with attention to the fruit's constituent profile. Animal. PubMed PMID: 19548275
- Iridoid anti-inflammatory activity — deacetylasperulosidic acid and asperulosidic acid are noni's chemical signature and the compounds most plausibly behind any real anti-inflammatory effect. Mostly in vitro and animal. PubMed topic search.
- Human joint-pain and arthritis reports — small and short. PubMed topic search.
Evidence tier: preliminary. Reasonably consistent animal analgesia; human data too small to show a benefit. Full discussion in Pain and Joint Comfort.
Key Research: Immune Activity and Antioxidant Chemistry
- Hirazumi and Furusawa, Phytotherapy Research, 1999 — an immunomodulatory polysaccharide-rich substance from noni fruit juice with antitumour activity in mice. The foundation of the immune claim, and it is a mouse study. Animal. PubMed PMID: 10441776
- Hiramatsu and colleagues, Cancer Letters, 1993 — induction of normal phenotypes in ras-transformed cells by damnacanthal from Morinda citrifolia. This single cell-culture paper is where most of the "noni fights cancer" marketing ultimately comes from. In vitro, isolated compound. PubMed PMID: 7693328
- Wang and colleagues, Chemistry Central Journal, 2009 — "Antioxidant activity of noni juice in heavy smokers": a 30-day placebo-controlled trial in 285 heavy smokers (placebo, 29.5 mL or 118 mL of noni juice a day). Plasma superoxide anion radicals and lipid hydroperoxides fell in both noni groups and not in the placebo group. Human, short, surrogate endpoints. PubMed PMID: 19807926
- Wang and colleagues, Nutrition and Cancer, 2009 — "Morinda citrifolia (noni) reduces cancer risk in current smokers by decreasing aromatic DNA adducts": of 283 smokers enrolled, 203 completed the 1-month trial, and aromatic DNA adducts in blood cells fell by 44.9% after 1 to 4 oz of noni juice a day. The title's "reduces cancer risk" rests on this blood marker, not on cancer cases. Human, short, surrogate endpoint. PubMed PMID: 19838937
- Wang and colleagues, The Scientific World Journal, 2012 — noni juice and serum lipid profiles and other risk markers in 132 heavy smokers over one month. Human, small, short, surrogate endpoints. PubMed PMID: 23097636
- Wang and colleagues, Food Science & Nutrition, 2013 — reduction in lipid-peroxidation-derived DNA adducts in 245 heavy smokers over 1 month. Same caveats. PubMed PMID: 24804023
- Potterat and colleagues, Journal of Agricultural and Food Chemistry, 2007 — independent analytical work identifying markers and quantifying constituents across noni powders and commercial products, and the best demonstration of how much products differ from one another. PubMed PMID: 17696360
- Shin and colleagues, Nutrients, 2026 — "Fermented Noni Polysaccharides and Immune-Related Biomarkers in Adults with Recurrent URTIs: A Randomized, Double-Blind, Placebo-Controlled Trial". 100 adults aged 40 to under 75 who had had at least 2 upper respiratory tract infections (colds and similar infections) in the previous year took 975 mg a day of fermented noni polysaccharides or a placebo for 8 weeks. The number of infections at week 4, week 8 and overall did not differ significantly between the groups. Natural killer cell activity rose more in the noni group, but the difference was not statistically significant in the main analysis (p = 0.066, 0.087 and 0.145 at the three test ratios). The tablets were well tolerated, with no serious adverse events. Human, randomised, infection outcome. PubMed PMID: 42280334
Evidence tier: strong in vitro and animal signal, several small human surrogate-marker trials in smokers, and one 2026 trial that found no significant effect on the number of colds. Nothing here supports an immune or anticancer indication in people. Full discussion in Immune and Antioxidant.
Key Research: Energy, Quality of Life and Trial Design
- Issell and colleagues, Journal of Dietary Supplements, 2009 — a phase I dose-finding study in patients with advanced cancer that used quality-of-life instruments to help select a dose. It is the most methodologically transparent human noni study, and it was a dose-finding exercise, not a test of whether noni treats cancer. Preliminary human. PubMed PMID: 22435516
- Wang and colleagues, Acta Pharmacologica Sinica, 2002 — the most-cited noni review, and the reference behind a great deal of secondary writing. PubMed PMID: 12466051
- Placebo response in fatigue and wellbeing endpoints — essential context for why "I have more energy" testimonials cannot settle anything. PubMed topic search.
- Industry funding and outcome reporting in supplement trials — the methodological literature on why sponsorship matters. PubMed topic search.
Evidence tier: preliminary human at best. Full discussion in Energy and Quality of Life.
Traditional Use, Described Accurately
Noni is one of the canonical Polynesian "canoe plants" — species carried deliberately across the Pacific because they were too useful to leave behind — and its traditional profile deserves to be described accurately rather than repurposed as advertising.
- Dye. The root yields morindone and related anthraquinone pigments giving reds, purples and yellows. For centuries this was noni's most economically important use, particularly in India and Java.
- Famine food. Eaten in Polynesia, Fiji and parts of Southeast Asia in times of scarcity, often with salt. It fruits year-round and reliably, which is exactly what a famine food needs to do. It was not a favoured food.
- Hawaiian lā‘au lapa‘au. Fruit preparations for wounds, boils and digestive complaints; warmed leaves applied over joints and the abdomen.
- Southeast Asia. In Indonesia mengkudu is a Jamu staple used for hypertension and diabetes; in Thailand bai yo leaves are genuinely culinary, used to wrap and steam fish; in Vietnam nhàu root and fruit are used for joint pain.
- Northern Australia. A traditional Aboriginal bush food and medicine.
What is not traditional: a sweetened daily juice drunk by healthy people as a general tonic. The ethnobotanical record describes a dye plant, a subsistence food, and targeted remedies — mostly leaf and root preparations for specific complaints. Daily wellness consumption is a 1990s commercial invention, and presenting it as ancient Polynesian practice misrepresents the tradition it borrows from. Evidence tier: traditional use only. Recorded as history, not offered as proof.
External Resources
- European Food Safety Authority — the source for the novel-food opinions on noni juice, purée, powder and leaves. Search the site for Morinda citrifolia to read the opinions rather than the marketing summaries of them.
- LiverTox (U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases) — the free reference database on drug- and herb-induced liver injury.
- U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health — plain-language summaries of botanical evidence, including noni.
- National Kidney Foundation — potassium guidance for people with kidney disease.
- Memorial Sloan Kettering — About Herbs — conservative, referenced monographs written for people undergoing cancer treatment.
- MedlinePlus — U.S. National Institutes of Health consumer health information, useful for the drug names mentioned in the interaction lists.
Connections
- All Herbs
- Noni (Morinda citrifolia) — main page
- Liver Cirrhosis
- Fatty Liver Disease
- Nephrology and Hepatology
- Kidney Disease
- Acute Kidney Injury
- Autoimmune Hepatitis
- Liver Function Tests
- Comprehensive Metabolic Panel
- Potassium
- Potassium Toxicity
- Osteoarthritis
- Rheumatoid Arthritis
- Milk Thistle
- Turmeric
- Antioxidants
- Toxins
Safety note and disclaimer. This page is health education, not medical advice. The liver case reports and the potassium data raise a concern for people with liver disease or a history of drug-induced liver injury, and for people with chronic kidney disease or on dialysis; there is no safety data for pregnancy or breastfeeding. Noni juice was measured at 56.3 mEq/L of potassium, similar to orange and tomato juice, and a man with long-term kidney disease developed hyperkalaemia (high blood potassium) while drinking it. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, potassium-sparing diuretics, trimethoprim and potassium supplements also raise potassium, so noni adds to their load; warfarin, methotrexate and other medicines that stress the liver add to the liver concern. One of the published liver cases ended in an urgent liver transplant. Jaundice (yellow skin or eyes), dark urine, pale stools, right-upper-abdominal pain, itching or unexplained fatigue and nausea are signs of liver injury that hospitals treat as urgent, and liver function tests are how it is measured. Noni is not a treatment for cancer, diabetes, kidney disease or inflammatory arthritis.